Bio-Rad Laboratories Inc Class A (BIO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

1000 ALFRED NOBEL DRIVE HERCULES, CA 94547

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It has two segments. The Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. These products are sold to university and medical school laboratories, pharmaceutical and biotechnology companies, food testing laboratories, and government and industrial research facilities. The Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. In November 2006, it purchased Ciphergen Biosystems, Inc.'s ProteinChip Systems business and worldwide technology rights to its Surface Enhanced Laser Desorption/ionization.

Data based on most recent fiscal year report
Market Cap7.414 Billion Shares Outstanding29.76 Million Avg Volume279.646 Thousand
1-Yr BETA vs S&P TR1.07 Current Ratio3.93 Quick Ratio2.75

Are you looking for this stock instead?

View SEC Filings from BIO instead.
Q2 2019 All Institutions Hedge Funds 1
To trade BIO now:
Filers who had this stock in their top 10: 11 4 (0.41%)
13F Filers holding this stock: 322 45 (4.65%)
Aggregate 13F shares on 06/30/2019: 18.5 Million 3.793 Million
Aggregate 13F shares on 03/31/2019: 19.225 Million 3.968 Million
Percent change: -3.77% -4.42%
Funds creating new positions: 39 6
Funds Adding to an existing position: 101 16
Funds closing out their position: 52 15
Funds reducing their position: 128 21
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

635 total shares from 2 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CROWLEY MICHAEL EVP, GBL COMMERCIAL OPERATIONS

  • Officer
3,100 2019-08-14 7

ERNST TIMOTHY S EVP, GENERAL COUNSEL & SEC

  • Officer
103 2019-08-14 5

LOVE TED W SEE REMARKS

  • Officer
  • Director
1,182,867 2019-08-01 0

LAST ANDREW J.

  • Director
0 2019-07-17 2

SODERBERG SHAWN MARIE EVP, GC & SECRETARY

  • Officer
0 2019-07-16 0

EDWARDS JEFFREY L

  • Director
0 2019-06-20 0

HINCKLEY GREGORY K

0 2019-06-13 0

TSINGOS CHRISTINE A

  • Director
30,509 2019-05-22 6

MAGNI GIOVANNI EVP, CHIEF STRATEGY OFFICER

  • Officer
13,617 2019-05-15 6

SCHWARTZ NORMAN D CHAIRMAN, PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
4,761,196 2019-05-13 7

DASKAL ILAN EVP, CFO

  • Officer
0 2019-04-08 2

PINKSTON ARNOLD A CLO & CORPORATE SECRETARY

  • Officer
24,161 2019-03-04 0

MCCOMB JOEL

  • Director
0 2018-12-14 0

STARK JAMES R VP, CORPORATE CONTROLLER

  • Officer
0 2018-12-12 6

TUMOLO ANNETTE EXECUTIVE VICE PRESIDENT

  • Officer
1,504 2018-12-11 6

SCHWARTZ ALICE N

  • Director
  • 10% Owner
7,285,857 2018-12-10 1

SCHWARTZ STEVEN D

  • 10% Owner
4,461,788 2018-12-10 1

HUTTON RONALD W VICE PRESIDENT AND TREASURER

  • Officer
4,000 2018-09-11 5

HERTIA JOHN EXECUTIVE VICE PRESIDENT

  • Officer
14,767 2018-09-11 5

GOETZ JOHN EVP, CHIEF OPERATING OFFICER

  • Officer
66,473 2017-09-13 0

HALL SHANNON EXECUTIVE VICE PRESIDENT

  • Officer
565 2017-09-13 0

PEI MELINDA LITHERLAND

  • Director
0 2017-04-25 0

SCHWARTZ DAVID CHAIRMAN OF THE BOARD

  • Officer
  • Director
  • 10% Owner
7,390,891 2011-12-14 0

WADLER SANFORD VP, GENERAL COUNSEL, SECRETARY

  • Officer
11,936 2011-12-14 0

CRUTCHFIELD BRADFORD VICE PRESIDENT

  • Officer
5,811 2011-11-16 0

NEFF DEBORAH J

  • Director
0 2011-10-26 0

BENNETT JAMES

  • Director
80,000 2010-11-19 0

HILLMAN AL

  • Director
15,160 2009-12-14 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CROWLEY MICHAEL - Officer EVP, GBL COMMERCIAL OPERATIONS

2019-08-14 S 325 $320.00 d 3,100 3,100.00 direct

ERNST TIMOTHY S - Officer EVP, GENERAL COUNSEL & SEC

2019-08-14 S 310 $320.00 d 103 102.97 direct
Click here to report any possible errors with this stock listing.

Elevate your investments